Search research articles
Contact Us
Filters
Showing results (21-30 of 134) with videos related to
Page
of 14
Sort By:
The Journal of Biological Chemistry
|
July 20, 2011
Nuclear factor-kappaB (NF-kappaB) mediates a protective response in cancer cells treated with inhibitors of fatty acid synthase
Colleen R M Lemmon, Ju-Hyung Woo, Ellen Tully, et al.
Acta Cytologica
|
May 9, 2025
Assessment of ER, PR and HER2 on cell blocks and core needle biopsies in metastatic breast cancer: a real-world experience
Chen Lossos, Sandra Sanchez, Hiro Nonogaki, et al.
Oncogene
|
September 5, 2025
Correction: Hypermethylation of 14-3-3 σ (stratifin) is an early event in breast cancer
Christopher B Umbricht, Ella Evron, Edward Gabrielson, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
January 7, 2017
Heterogeneous expression of PD-L1 in pulmonary squamous cell carcinoma and adenocarcinoma: implications for assessment by small biopsy
Thomas J Gniadek, Qing Kay Li, Ellen Tully, et al.
Breast Cancer Research and Treatment
|
December 5, 2002
Mucinous cancers have fewer genomic alterations than more common classes of breast cancer
Hiroaki Fujii, Ramaswamy Anbazhagan, Daniel M Bornman, et al.
Human Pathology
|
January 23, 2013
Comparison of EGFR and KRAS mutations in primary and unpaired metastatic lung adenocarcinoma with potential chemotherapy effect
Delicia Munfus-McCray, Min Cui, Zhen Zhang, et al.
Cancer Chemotherapy and Pharmacology
|
May 13, 2004
Induction of spermidine/spermine N1-acetyltransferase in breast cancer tissues treated with the polyamine analogue N1, N11-diethylnorspermine
Edward Gabrielson, Ellen Tully, Amy Hacker, et al.
Clinical Proteomics
|
November 2, 2013
Aberrant Mucin5B expression in lung adenocarcinomas detected by iTRAQ labeling quantitative proteomics and immunohistochemistry
Yan Li, Xiangchun Wang, Minghui Ao, et al.
Human Pathology
|
April 19, 2011
EGFR and KRAS mutations in metastatic lung adenocarcinomas
Delicia Munfus-McCray, Shuko Harada, Christina Adams, et al.
The American Journal of Surgical Pathology
|
September 18, 2012
Utility of GATA3 immunohistochemistry in differentiating urothelial carcinoma from prostate adenocarcinoma and squamous cell carcinomas of the uterine cervix, anus, and lung
Alex Chang, Ali Amin, Edward Gabrielson, et al.
Page
of 14
Search research articles
Search
Showing results (21-30 of 134) with videos related to
Sort By:
Page
of 14
The Journal of Biological Chemistry
|
July 20, 2011
Nuclear factor-kappaB (NF-kappaB) mediates a protective response in cancer cells treated with inhibitors of fatty acid synthase
Colleen R M Lemmon, Ju-Hyung Woo, Ellen Tully, et al.
Acta Cytologica
|
May 9, 2025
Assessment of ER, PR and HER2 on cell blocks and core needle biopsies in metastatic breast cancer: a real-world experience
Chen Lossos, Sandra Sanchez, Hiro Nonogaki, et al.
Oncogene
|
September 5, 2025
Correction: Hypermethylation of 14-3-3 σ (stratifin) is an early event in breast cancer
Christopher B Umbricht, Ella Evron, Edward Gabrielson, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
January 7, 2017
Heterogeneous expression of PD-L1 in pulmonary squamous cell carcinoma and adenocarcinoma: implications for assessment by small biopsy
Thomas J Gniadek, Qing Kay Li, Ellen Tully, et al.
Breast Cancer Research and Treatment
|
December 5, 2002
Mucinous cancers have fewer genomic alterations than more common classes of breast cancer
Hiroaki Fujii, Ramaswamy Anbazhagan, Daniel M Bornman, et al.
Human Pathology
|
January 23, 2013
Comparison of EGFR and KRAS mutations in primary and unpaired metastatic lung adenocarcinoma with potential chemotherapy effect
Delicia Munfus-McCray, Min Cui, Zhen Zhang, et al.
Cancer Chemotherapy and Pharmacology
|
May 13, 2004
Induction of spermidine/spermine N1-acetyltransferase in breast cancer tissues treated with the polyamine analogue N1, N11-diethylnorspermine
Edward Gabrielson, Ellen Tully, Amy Hacker, et al.
Clinical Proteomics
|
November 2, 2013
Aberrant Mucin5B expression in lung adenocarcinomas detected by iTRAQ labeling quantitative proteomics and immunohistochemistry
Yan Li, Xiangchun Wang, Minghui Ao, et al.
Human Pathology
|
April 19, 2011
EGFR and KRAS mutations in metastatic lung adenocarcinomas
Delicia Munfus-McCray, Shuko Harada, Christina Adams, et al.
The American Journal of Surgical Pathology
|
September 18, 2012
Utility of GATA3 immunohistochemistry in differentiating urothelial carcinoma from prostate adenocarcinoma and squamous cell carcinomas of the uterine cervix, anus, and lung
Alex Chang, Ali Amin, Edward Gabrielson, et al.
Page
of 14